📰 Zai Lab News
Page 56 - Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.
May 18, 2022
Argenx (NASDAQ:ARGX – Get Rating) and TC Biopharm (NASDAQ:TCBP – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation. Valuation and Earnings This table compares argenx and TC Biopharm’s gross […]
May 12, 2022
Zai Lab (NASDAQ:ZLAB – Get Rating) had its price objective decreased by equities research analysts at Citigroup from $198.00 to $193.00 in a research report issued on Thursday, The Fly reports. Other analysts have also issued reports about the company. JPMorgan Chase & Co. reduced their price objective on Zai Lab from $136.00 to $112.00 […]
May 12, 2022
Taiho licensed the drug to Cullinan in 2019 but has now acquired Cullinan subsidiary Cullinan Pearl to resume codevelopment and commercialization of the program.
May 11, 2022
Start Time: 08:00 End Time: 08:48 Zai Lab Limited (NASDAQ:NASDAQ:ZLAB) Q1 2022 Earnings Conference Call May 11, 2022, 08:00 AM ET Company Participants Samantha Du - Founder, Chairperson and...
May 11, 2022
China’s leading biotechnology and other health care companies have continued to grow revenues rapidly over the past two years and are expected to see strong growth in the years to come.
May 10, 2022
Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET...
May 9, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
May 9, 2022
Samantha Kleinberg is fascinated by data, especially the gusher of data coming from the medical field. As a computer science professor at Stevens Institute of Technology, she has analyzed blood glucose levels from people living with diabetes and the
May 5, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 5, 2022
- Study met primary endpoint, demonstrating a higher proportion of sustained platelet response with VYVGART treatment compared to placebo (p=0.0316);...